IP Library Granted Patent US 9,974,866
Granted Patent B2
US 9,974,866 · App. 13/634,717 · Granted May 22, 2018

Protein-poly(2-oxazoline) conjugates for enhanced cellular delivery and transport across biological barriers

Inventors: Alexander V. Kabanov (Omaha, NE); Jing Tong (Omaha, NE)
Assignee: Board of Regents of the University of Nebraska
A61K47/59A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,974,866
App. No.
13/634,717
Granted
May 22, 2018
Kind
B2
Abstract

The present invention provides polymer-polypeptide conjugates comprising a poly(2-oxazoline) amphiphilic block copolymer linked to a polypeptide and methods of use thereof.

Claims (23)

1. A polymer-polypeptide conjugate comprising at least one amphiphilic block copolymer linked to at least one polypeptide,

wherein said amphiphilic block copolymer comprises at least one hydrophilic segment and at least one hydrophobic segment, wherein said hydrophilic segment is a hydrophilic poly(2-oxazoline), wherein said hydrophobic segment is a hydrophobic poly(2-oxazoline), and wherein said amphiphilic block copolymer comprises the formula:

wherein x and y are independently selected between 10 and about 100; one of R 1 and R 2 is selected from the group consisting of —H, —OH, —NH 2 , —SH, —CH 3 , —CH 2 CH 3 , and an alkyl comprising 1 or 2 carbon atoms; and the other R group is an alkyl or an aryl.

2. The conjugate of claim 1 , wherein said hydrophilic segment is poly(2-methyl-2-oxazoline) or poly(2-ethyl-2-oxazoline).

3. The conjugate of claim 1 , wherein said hydrophobic segment is poly(2-butyl-2-oxazoline).

4. The conjugate of claim 1 , wherein said polypeptide is a therapeutic agent, a diagnostic agent, or a cosmetic agent.

5. The conjugate of claim 1 , wherein said amphiphilic block copolymer is linked to said polypeptide via a linker.

6. The conjugate of claim 1 , wherein said amphiphilic block copolymer is covalently linked to said polypeptide.

7. The conjugate of claim 1 , wherein said amphiphilic copolymer comprises the formula:

wherein R 1 is selected from the group consisting of —H, —OH, —NH 2 , —SH, —CH 3 , —CH 2 CH 3 , and an alkyl comprising 1 or 2 carbon atoms; and R 2 is an alkyl or an aryl.

8. A composition comprising at least one conjugate of claim 1 and at least one carrier.

9. The conjugate of claim 1 , wherein said polypeptide is linked to a terminus of said amphiphilic block copolymer.

10. The conjugate of claim 5 , wherein said polypeptide is linked to a terminus of said amphiphilic block copolymer via said linker.

11. The conjugate of claim 1 , wherein said hydrophilic segment is poly(2-methyl-2-oxazoline) or poly(2-ethyl-2-oxazoline) and wherein said hydrophobic segment is poly(2-butyl-2-oxazoline).

12. The conjugate of claim 11 , wherein said amphiphilic block copolymer is (2-methyl-2-oxazoline) 50 -(2-butyl-2-oxazoline) 20 or (2-ethyl-2-oxazoline) 50 -(2-butyl-2-oxazoline) 20 .

13. The conjugate of claim 11 , wherein said polypeptide is linked to a terminus of said amphiphilic block copolymer via said linker and wherein said polypeptide is superoxide dismutase.

14. The conjugate of claim 12 , wherein said polypeptide is linked to a terminus of said amphiphilic block copolymer via said linker and wherein said polypeptide is superoxide dismutase.

15. The conjugate of claim 13 , wherein said linker is non-biodegradable.

16. The conjugate of claim 14 , wherein said linker is non-biodegradable.

17. The conjugate of claim 5 , wherein said linker is non-biodegradable.

18. The conjugate of claim 1 , wherein said polypeptide is linked to a terminus of said hydrophobic segment of said amphiphilic block copolymer.

19. The conjugate of claim 5 , wherein said polypeptide is linked to a terminus of said hydrophobic segment of said amphiphilic block copolymer via said linker.

20. The conjugate of claim 11 , wherein said polypeptide is linked to the terminus of said poly(2-butyl-2-oxazoline).

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 14, 2012
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029294/0597 →
Continuity (2)
Provisional Application 61321617 · Apr 7, 2010
Related Publication 20130017166A1 · Jan 17, 2013